184 related articles for article (PubMed ID: 21752360)
1. Predicting DNA-mediated drug delivery in interior carcinoma using electromagnetically excited nanoparticles.
Ghosh S; Das T; Chakraborty S; Das SK
Comput Biol Med; 2011 Sep; 41(9):771-9. PubMed ID: 21752360
[TBL] [Abstract][Full Text] [Related]
2. Smart drug delivery through DNA/magnetic nanoparticle gates.
Ruiz-Hernández E; Baeza A; Vallet-Regí M
ACS Nano; 2011 Feb; 5(2):1259-66. PubMed ID: 21250653
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy.
Zhao Y; Lu Y; Hu Y; Li JP; Dong L; Lin LN; Yu SH
Small; 2010 Nov; 6(21):2436-42. PubMed ID: 20878636
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Mahmoudi M; Sant S; Wang B; Laurent S; Sen T
Adv Drug Deliv Rev; 2011; 63(1-2):24-46. PubMed ID: 20685224
[TBL] [Abstract][Full Text] [Related]
5. Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy.
Mejías R; Pérez-Yagüe S; Gutiérrez L; Cabrera LI; Spada R; Acedo P; Serna CJ; Lázaro FJ; Villanueva A; Morales Mdel P; Barber DF
Biomaterials; 2011 Apr; 32(11):2938-52. PubMed ID: 21277630
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
Kohler N; Sun C; Wang J; Zhang M
Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
[TBL] [Abstract][Full Text] [Related]
8. Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect.
Podduturi VP; Magaña IB; O'Neal DP; Derosa PA
Comput Methods Programs Biomed; 2013 Oct; 112(1):58-68. PubMed ID: 23871689
[TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
10. Magnetic nanoparticle-based drug delivery for cancer therapy.
Tietze R; Zaloga J; Unterweger H; Lyer S; Friedrich RP; Janko C; Pöttler M; Dürr S; Alexiou C
Biochem Biophys Res Commun; 2015 Dec; 468(3):463-70. PubMed ID: 26271592
[TBL] [Abstract][Full Text] [Related]
11. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
12. In silico studies of magnetic microparticle aggregations in fluid environments for MRI-guided drug delivery.
Vartholomeos P; Mavroidis C
IEEE Trans Biomed Eng; 2012 Nov; 59(11):3028-38. PubMed ID: 22907964
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery to tumours: recent strategies.
Reddy LH
J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
[TBL] [Abstract][Full Text] [Related]
14. Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.
Sinek J; Frieboes H; Zheng X; Cristini V
Biomed Microdevices; 2004 Dec; 6(4):297-309. PubMed ID: 15548877
[TBL] [Abstract][Full Text] [Related]
15. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
16. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
[TBL] [Abstract][Full Text] [Related]
18. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy.
Kempe M; Kempe H; Snowball I; Wallén R; Arza CR; Götberg M; Olsson T
Biomaterials; 2010 Dec; 31(36):9499-510. PubMed ID: 20732712
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for drug delivery in cancer treatment.
Haley B; Frenkel E
Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
[TBL] [Abstract][Full Text] [Related]
20. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
Chen JN; Shen Q; Li SS
Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
